---
document_datetime: 2023-09-21 17:50:50
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/provenge-epar-all-authorised-presentations_en.pdf
document_name: provenge-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.3927195
conversion_datetime: 2025-12-17 15:14:07.802063
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
MA (EU) Number

EU/1/13/867/001

--1

6

â‰¥ 50x10

(Invented)

name

PROVENGE

CD54+ cells/250mL

Strength

--1

Pharmaceutical Form dispersion for infusion

Route of

Administration

Intravenous use

Immediate

Packaging

Bag

Content

(concentration)

250 ml

Medicinal product no longer authorised

Pack size

1 bag